Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Phoon

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Current Molecular Medicine|June 5, 2014
Combination therapy with hepatocyte growth factor and oseltamivir confers enhanced protection against influenza viral pneumoniaT Narasaraju, E Yang, R P Samy, et al.
Journal of Medical Virology|May 29, 2009
Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motifW P Poh, T Narasaraju, N A Pereira, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 19, 2012
Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workersJ P Hsu, M C Phoon, Gerald C H Koh, et al.
Vaccine|August 21, 2010
Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strainsVernon J Lee, Joshua K Tay, Mark I C Chen, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Current Molecular Medicine|June 5, 2014
Combination therapy with hepatocyte growth factor and oseltamivir confers enhanced protection against influenza viral pneumoniaT Narasaraju, E Yang, R P Samy, et al.
Journal of Medical Virology|May 29, 2009
Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motifW P Poh, T Narasaraju, N A Pereira, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 19, 2012
Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workersJ P Hsu, M C Phoon, Gerald C H Koh, et al.
Vaccine|August 21, 2010
Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strainsVernon J Lee, Joshua K Tay, Mark I C Chen, et al.
Pageof 3